ReviewCancers2024

The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review.

Maria Benkhadra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.